General Biophysics
Our Research Initiatives
Neurodegeneration and Aging
Explore our approach to Alzheimer's disease.
Approximately 30 million people have Alzheimer’s Disease (AD). Unfortunately, there is no cure. We are developing a therapeutic approach to target microglial dysregulation. Our drug-device combination product is based on the proprietary xenon gas mixture delivered to patients through the automatic inhalation system.
Opioid Use Disorder
Promising Treatment for substance use disorder and pain management
Opioid Use Disorder (OUD) affects 4.8 million people in the United States, continuing to devastate lives and communities. Through its xenon inhalation technology, General Biophysics is developing a therapy designed to alleviate opioid withdrawal symptoms and facilitate opioid tapering—translating cutting-edge neuroscience into effective treatment.
Cellular Preservation Technology (CPT)
Discover our advancements in cell preservation.
We are developing innovative solutions to improve the availability of precious biological agents with potent therapeutic applications. Our initial product is a revolutionary platelet storage system which transforms the useful lifespan of platelets from five to fourteen days.